LogicBio Therapeutics, Inc.

The partners at Andera Life Sciences have been reflecting on a busy week which saw the France-headquartered private equity firm wave goodbye to portfolio company Amolyt Pharma , sold to AstraZeneca

Cellectis SA has pulled off a major coup by linking up with AstraZeneca PLC for a gene editing and manufacturing pact that could potentially be worth multi-millions of dollars, with the UK giant ta

The small-to-medium biotech sector has experienced one of its most severe downturns in 2022, with funding drying up for scores of companies and many having to resort to cutting jobs and pipeline progr

Europe's biotechs have always held their own when it comes to scientific innovation but despite the tricky climate for financing, there are plenty of firms that have the potential to go from discovery